A system for quickly analyzing proteins in individual cells
A Microfluidic/Nanofluidic System for Rapid Single Cell Proteomics
['FUNDING_OTHER'] · FLUIDISPEC LLC · NIH-10547040
This study is working on a new way to quickly and easily analyze proteins from individual cells, which could help us understand diseases better and lead to more personalized treatments for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FLUIDISPEC LLC (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10547040 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new microfluidic and nanofluidic system that allows for the rapid analysis of proteins at the single-cell level. By improving the methods used to isolate and analyze proteins, this project aims to overcome the challenges posed by traditional techniques that often require larger cell populations. The innovative approach seeks to minimize sample loss and enhance the concentration of proteins, which is crucial for understanding the biological implications of cellular differences. Patients may benefit from insights gained into how diseases manifest at the protein level, potentially leading to more targeted therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that exhibit significant cellular heterogeneity, such as cancer or autoimmune diseases.
Not a fit: Patients with conditions that do not involve significant protein-level changes or cellular heterogeneity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise diagnostics and treatments for diseases by understanding protein behavior in individual cells.
How similar studies have performed: While single-cell proteomics is a growing field, this specific approach using microfluidic and nanofluidic systems represents a novel method that has not been widely tested.
Where this research is happening
PHILADELPHIA, UNITED STATES
- FLUIDISPEC LLC — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TIMPERMAN, AARON T — FLUIDISPEC LLC
- Study coordinator: TIMPERMAN, AARON T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.